School of Medicine, Southeast University, Nanjing, China.
Department of General Surgery, Affiliated Zhongda Hospital, Nanjing, China.
Int J Surg. 2017 Nov;47:18-24. doi: 10.1016/j.ijsu.2017.09.019. Epub 2017 Sep 18.
Esophagojejunal anastomotic leakage (EJAL) is considered to be one of the most serious complications after total gastrectomy (TG), despite improvements in surgical instruments and technique. The occurrence of EJAL would cause poorer quality of life, prolonged hospital stay, and increased surgery-related costs and mortality. Although there is ever-increasing knowledge about EJAL, the optimal management is controversial. In the present review, we aim to demonstrate the effective management by focus on the possible risk factors, potentially useful preventive strategies, and several kinds of treatments in esophagojejunal anastomotic leakage after total gastrectomy for gastric cancer.
食管空肠吻合口瘘（EJAL）被认为是全胃切除术后（TG）最严重的并发症之一，尽管手术器械和技术有所改进。EJAL 的发生会导致生活质量下降、住院时间延长、手术相关费用增加和死亡率增加。尽管人们对 EJAL 的认识不断提高，但最佳治疗方法仍存在争议。在本综述中，我们旨在通过关注胃癌全胃切除术后食管空肠吻合口瘘的可能危险因素、潜在有用的预防策略和几种治疗方法，来展示有效的治疗方法。
